Sfoglia per Rivista BAILLIERE'S BEST PRACTICE
Management of tyrosine kinase inhibitors (TKI) side effects in differentiated and medullary thyroid cancer patients
2017 C. Resteghini, S. Cavalieri, D. Galbiati, R. Granata, S. Alfieri, C. Bergamini, P. Bossi, L.F.L. Licitra, L..D. Locati
Morbidity and mortality in men: Role of androgens
2022 G. Fallara, E. Pozzi, C. Corsini, F. Belladelli, L. Boeri, P. Capogrosso, F. Montorsi, A. Salonia
The multiple genetic causes of central hypothyroidism
2017 L. Persani, M. Bonomi
Multiple hormone resistance and alterations of GPCRs signaling
2018 G. Mantovani, F.M. Elli
Mutations in the Gs alpha gene causing hormone resistance
2006 G. Mantovani, A. Spada
Non classical complications of primary hyperparathyroidism
2018 I. Chiodini, E. Cairoli, S. Palmieri, J. Pepe, M.D. Walker
Parathyroid hormone resistance syndromes – Inactivating PTH/PTHrP signaling disorders (iPPSDs)
2018 F.M. Elli, A. Pereda, A. Linglart, G. Perez de Nanclares, G. Mantovani
Pituitary incidentalomas
2012 A. Lania, P. Beck Peccoz
Pituitary tumours : TSH-secreting adenomas
2009 P. Beck Peccoz, L. Persani, D. Mannavola, I. Campi
Syndromes of hormone resistance in the hypothalamic-pituitary-thyrod axis
2006 P. Beck-Peccoz, L. Persani, D. Calebiro, M. Bonomi, D. Mannavola, I. Campi
Therapeutic effects of androgens for cachexia
2021 L. Giovanelli, R. Quinton
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile